UCLA Researchers Create Universal Single-Product Immunotherapy for Breast Cancer
Triple-negative breast cancer (TNBC) has long posed a formidable challenge within oncology, notorious for its aggressive nature and limited treatment ...
Triple-negative breast cancer (TNBC) has long posed a formidable challenge within oncology, notorious for its aggressive nature and limited treatment ...
In the evolving landscape of cancer treatment, researchers are consistently on the hunt for innovative strategies to enhance therapeutic efficacy, ...
A groundbreaking study emerging from the Icahn School of Medicine at Mount Sinai illuminates a promising new avenue in the ...
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound ...
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
In a groundbreaking study published recently in Nature Communications, researchers have unveiled a novel immunomodulatory strategy that promises to revolutionize ...
In the dynamic landscape of cancer research, the quest for innovative treatment avenues remains paramount, particularly in the context of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine